142 related articles for article (PubMed ID: 12492247)
1. Light and electron microscopic analysis of liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy.
Ros S; Juanola X; Condom E; Cañas C; Riera J; Guardiola J; Del Blanco J; Rebasa P; Valverde J; Roig-Escofet O
Scand J Rheumatol; 2002; 31(6):330-6. PubMed ID: 12492247
[TBL] [Abstract][Full Text] [Related]
2. Light and electron microscopic analysis of sequential liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy. Followup over long treatment intervals and correlation with clinical and laboratory variables.
Kremer JM; Kaye GI; Kaye NW; Ishak KG; Axiotis CA
Arthritis Rheum; 1995 Sep; 38(9):1194-203. PubMed ID: 7575712
[TBL] [Abstract][Full Text] [Related]
3. Hepatic fibrosis in rheumatoid arthritis patients treated with methotrexate: application of a new semi-quantitative scoring system.
Richard S; Guerret S; Gerard F; Tebib JG; Vignon E
Rheumatology (Oxford); 2000 Jan; 39(1):50-4. PubMed ID: 10662873
[TBL] [Abstract][Full Text] [Related]
4. Electron microscopic analysis of sequential liver biopsy samples from patients with rheumatoid arthritis. Correlation with light microscopic findings.
Kremer JM; Kaye GI
Arthritis Rheum; 1989 Oct; 32(10):1202-13. PubMed ID: 2803323
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal measurement of methotrexate liver concentrations does not correlate with liver damage, clinical efficacy, or toxicity during a 3.5 year double blind study in rheumatoid arthritis.
Fathi NH; Mitros F; Hoffman J; Straniero N; Labreque D; Koehnke R; Furst DE
J Rheumatol; 2002 Oct; 29(10):2092-8. PubMed ID: 12375317
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients.
Erickson AR; Reddy V; Vogelgesang SA; West SG
Arthritis Rheum; 1995 Aug; 38(8):1115-9. PubMed ID: 7639808
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.
Mori S; Arima N; Ito M; Fujiyama S; Kamo Y; Ueki Y
PLoS One; 2018; 13(8):e0203084. PubMed ID: 30142184
[TBL] [Abstract][Full Text] [Related]
8. Significance of liver biopsy for the evaluation of methotrexate-induced liver damage in patients with rheumatoid arthritis.
Osuga T; Ikura Y; Kadota C; Hirano S; Iwai Y; Hayakumo T
Int J Clin Exp Pathol; 2015; 8(2):1961-6. PubMed ID: 25973089
[TBL] [Abstract][Full Text] [Related]
9. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
[TBL] [Abstract][Full Text] [Related]
10. Significant changes in serum AST across hepatic histological biopsy grades: prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritis.
Kremer JM; Furst DE; Weinblatt ME; Blotner SD
J Rheumatol; 1996 Mar; 23(3):459-61. PubMed ID: 8832983
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
Müller RB; von Kempis J; Haile SR; Schiff MH
Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
[TBL] [Abstract][Full Text] [Related]
12. Hepatic ultrastructure after methotrexate therapy for rheumatoid arthritis.
Bjorkman DJ; Hammond EH; Lee RG; Clegg DO; Tolman KG
Arthritis Rheum; 1988 Dec; 31(12):1465-72. PubMed ID: 3196365
[TBL] [Abstract][Full Text] [Related]
13. The effect of long-term methotrexate therapy on hepatic fibrosis in rheumatoid arthritis.
Bjorkman DJ; Boschert M; Tolman KG; Clegg DO; Ward JR
Arthritis Rheum; 1993 Dec; 36(12):1697-701. PubMed ID: 8250989
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: A cross-sectional controlled study with real-time two-dimensional shear wave elastography.
Erre GL; Cadoni ML; Meloni P; Castagna F; Mangoni AA; Piga M; Passiu G; Carru C; Zinellu A; Vidili G
Eur J Intern Med; 2019 Nov; 69():57-63. PubMed ID: 31474422
[TBL] [Abstract][Full Text] [Related]
15. Quantitative liver function in patients with rheumatoid arthritis treated with low-dose methotrexate: a longitudinal study.
Beyeler C; Reichen J; Thomann SR; Lauterburg BH; Gerber NJ
Br J Rheumatol; 1997 Mar; 36(3):338-44. PubMed ID: 9133966
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate.
Aponte J; Petrelli M
Arthritis Rheum; 1988 Dec; 31(12):1457-64. PubMed ID: 3196364
[TBL] [Abstract][Full Text] [Related]
17. The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis.
Hashkes PJ; Balistreri WF; Bove KE; Ballard ET; Passo MH
Arthritis Rheum; 1997 Dec; 40(12):2226-34. PubMed ID: 9416861
[TBL] [Abstract][Full Text] [Related]
18. Hepatotoxicity associated with low-dose, long-term methotrexate treatment of rheumatoid arthritis.
Szanto E; Sandstedt B; Kollberg B
Scand J Rheumatol; 1987; 16(4):229-34. PubMed ID: 3629206
[TBL] [Abstract][Full Text] [Related]
19. Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples.
Kremer JM; Lee RG; Tolman KG
Arthritis Rheum; 1989 Feb; 32(2):121-7. PubMed ID: 2920047
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate use in rheumatoid arthritis is associated with few clinically significant liver function test abnormalities.
Yazici Y; Erkan D; Harrison MJ; Nikolov NP; Paget SA
Clin Exp Rheumatol; 2005; 23(4):517-20. PubMed ID: 16095122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
